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The non-coding RNA subunit of telomerase provides
the template for telomerase activity. In diverse fungi,
30 end processing of telomerase RNA involves a
single cleavage by the spliceosome. Here, we
examine how human telomerase RNA (hTR) primary
transcripts are processed into the mature form of
precisely 451 nt. We find that the splicing inhibitor
isoginkgetin mimics the effects of RNA exosome in-
hibition and causes accumulation of long hTR tran-
scripts. Depletion of exosome components and
accessory factors reveals functions for the cap bind-
ing complex (CBC) and the nuclear exosome target-
ing (NEXT) complex in hTR turnover. Whereas longer
transcripts are predominantly degraded, shorter pre-
cursor RNAs are oligo-adenylated by TRF4-2 and
either processed by poly(A)-specific ribonuclease
(PARN) or degraded by the exosome. Our results
reveal that hTR biogenesis involves a kinetic compe-
tition between RNA processing and degradation and
suggest treatment options for telomerase insuffi-
ciency disorders.
INTRODUCTION
Telomerase is a ribonucleoprotein (RNP) complex, composed at
its core of the catalytic protein subunit telomerase reverse tran-
scriptase (TERT) and the RNA component telomerase RNA
(TER). TERT repeatedly copies the template region of TER onto
chromosome ends to replenish terminal DNA sequences lost
during normal DNA replication (Nandakumar and Cech, 2013).
The amount and activity of telomerase is tightly regulated in
many higher organisms, and the absence of telomerase expres-
sion in most somatic cells is thought to function as a tumor-sup-
pressive mechanism. Indeed, many cancers express high levels
of telomerase, and their continued proliferation depends on te-
lomerase activity (Stewart and Weinberg, 2006). Conversely,
mutations in telomerase components cause a spectrum of
degenerative syndromes including dyskeratosis congenita2232 Cell Reports 13, 2232–2243, December 15, 2015 ª2015 The Au(Mitchell et al., 1999b; Vulliamy et al., 2001), aplastic anemia (Vul-
liamy et al., 2002), and idiopathic pulmonary fibrosis (Armanios
et al., 2007).
Although the catalytic protein component of telomerase is well
conserved, the telomerase RNA subunit varies widely in length
and sequence among species (Podlevsky et al., 2008). Consis-
tent with the rapid evolution of the RNA, substantial differences
have been noted in how the primary telomerase RNA transcripts
are processed into the mature forms (Egan and Collins, 2012a).
In the budding yeast Saccharomyces cerevisiae, transcriptional
termination of TLC1 involves the Nrd1-Nab3-Sen1 (NNS)
pathway (Jamonnak et al., 2011; Kuehner et al., 2011; Noe¨l
et al., 2012). The NNS complex interacts with TRAMP, a nuclear
polyadenylation complex comprised of the poly(A) polymerases
Trf4/5, the zinc-knuckle RNA-binding proteins Air1/2, and the
RNA helicase Mtr4 (Tudek et al., 2014). TRAMP adds a short
stretch of oligo-adenosine to the 30 ends of RNAs, which are
then processed by the exosome, a multi-subunit complex with
30-50 exonuclease activity (Coy et al., 2013; Houseley et al.,
2006; Jamonnak et al., 2011; Kuehner et al., 2011; Lykke-Ander-
sen et al., 2009; Mitchell, 2014).
In fission yeast, an intron downstream of the mature 30 end of
TER1 is subject to the first cleavage reaction of splicing (Box
et al., 2008). Instead of second cleavage and exon ligation, the
50 exon is released through a mechanism previously described
to function in the discard of suboptimal splicing substrates
(Kannan et al., 2013; Mayas et al., 2006). Spliceosomal cleavage
appears to be widespread as a means of 30 end processing of
telomerase RNA subunits in fungi with known examples in fission
yeasts, Aspergilli, Neurospora, and Candida species (Gunisova
et al., 2009; Kannan et al., 2015; Kuprys et al., 2013; Qi et al.,
2015). Interestingly, conversion of splicing into a 30 end process-
ing event has arisen multiple times independently, as examina-
tion of a handful of species revealed three distinct mechanisms
for the uncoupling of the first and second transesterification re-
action (Kannan et al., 2013, 2015; Qi et al., 2015).
Unlike yeast telomerase RNAs, which share similarities with
small nuclear RNAs (Seto et al., 1999), vertebrate telomerase
RNAs contain a box H/ACA motif (Mitchell et al., 1999a), a
two-hairpin structure connected by a single-stranded hinge
ANANNA (H box) and a 30 single-stranded tail containing the
sequence ACA (Kiss et al., 2006, 2010). Most H/ACA box smallthors
nucleolar RNAs (snoRNAs) and small Cajal-body-specific RNAs
(scaRNAs) function as guides for site-specific pseudouridylation
of rRNAs and small nuclear RNAs (snRNAs), respectively. How-
ever, no putative target of the human telomerase RNA (hTR)
H/ACA motif has been identified, suggesting that the H/ACA
motif in hTRmay solely function to ensure processing and stabil-
ity of the RNA. Consistent with the H/ACA domain being critical
for hTR stability, several mutations in this region have been iden-
tified in patients with dyskeratosis congenita and cause defects
in processing and localization of hTR (Fu and Collins, 2003;
Theimer et al., 2007).
A key difference between mammalian telomerase RNAs and
the vast majority of H/ACA snoRNAs is that the former are tran-
scribed as independent units rather than being encoded within
introns of other genes. Intron-encoded snoRNAs require splicing
of the pre-mRNA to release a precursor that is debranched and
processed by 50 to 30 and 30 to 50 exonucleases to generate the
mature snoRNA (Kiss et al., 2006, 2010). hTR is transcribed
from its own polymerase II (pol II) promoter and accumulates in
the cell as an RNA of 451 nt in length. Longer forms have been
reported (Feng et al., 1995; Theimer et al., 2007), but how pri-
mary transcripts are processed had remained elusive thus far
(Figure S1).
RESULTS
Isoginkgetin Mimics the Effects of Inhibiting the RNA
Exosome
Different means of generating the mature 30 end of telomerase
RNA have been described in budding and fission yeasts (Fig-
ure S1). The spliceosome plays a direct role in the maturation
of S. pombe TER1 (Box et al., 2008), and splicing is required
for the release of intron-encoded H/ACA snoRNAs from pre-
mRNAs (Kiss et al., 2006, 2010). Whether the spliceosome is
also involved in the processing of hTR was not known. To
examine the requirement of the spliceosome for hTR processing,
we treated cells with isoginkgetin, a biflavonoid that inhibits spli-
ceosomal splicing (O’Brien et al., 2008). Following exposure of
cells for 12 hr, 30 extended forms of hTR increased by more
than 20-fold, reminiscent of results in fungi and supporting a
role for splicing in hTR processing (Figure 1A). No reduction in
the mature form of hTR was observed upon isoginkgetin treat-
ment (Figure S2A). This was not surprising, as half-lives between
7 and 32 days have been reported for hTR (Yi et al., 1999) and
less than 10% of hTR would therefore be expected to turn over
during the 12-hr exposure to isoginkgetin.
We next treated cells with spliceostatin A, another inhibitor of
pre-mRNA splicing (Kaida et al., 2007). Examination of 85,000
splicing units from Illumina RNA sequencing data revealed
substantive global inhibition of splicing upon treatment with
spliceostatin A, but only amodest reduction for isoginkgetin (Fig-
ure 1B). Nevertheless, unlike the effect observed with isoginkge-
tin, spliceostatin A treatment did not result in an increase in 30
extended forms of hTR (Figure 1C, right panel). Furthermore,
several mutations of putative 50 splice sites downstream of posi-
tion 451 failed to result in the accumulation of longer forms (data
not shown). Similarly, replacing 500 bp of downstream sequence
with unrelated DNA did not cause a reduction in mature hTR (FuCell Repand Collins, 2003). These observations were at odds with the hy-
pothesis that the spliceosome is directly involved in hTR
processing.
In examining differences in the effects of the two splicing in-
hibitors, we noticed that antisense reads upstream of the hTR lo-
cus increased specifically upon treatment with isoginkgetin
(Figure 1C, left panel). Such promoter upstream transcripts
(PROMPTs) have previously been observed to increase upon
depletion of the RNA exosome (Preker et al., 2008). Further sup-
porting the notion that isoginkgetin treatment mimics effects of
reduced exosome activity, 30 extended transcripts at RNU1-1
and replication-dependent histone loci (Andersen et al., 2013)
also increased in isoginkgetin-treated, but not spliceostatin
A-treated, cells (Figure S2B).
Longer Forms of hTR Are Preferentially Degraded
TheRNAexosomesupplies themajor 30 to 50 exonucleaseactivity
in the cell and is responsible for the processing and elimination of
many RNA species (Mitchell, 2014). To examine whether the
exosome is involved in hTRbiogenesis,wedepleted thecoreexo-
some component RRP40 and the two exosome-associated nu-
cleases RRP6 and DIS3, respectively (Figure 2A). Knockdown
of RRP40 resulted in co-depletion of RRP6 (Figure 2A, lane 2)
and caused a 13-fold increase in hTR forms extending by at least
50 nt beyond the mature 30 end (Figure 2B). Increases in 30
extended forms were also observed in the RRP6/DIS3 double
and individual knockdowns, with RRP6 knockdown having a
greater effect thanDIS3 knockdown (Figure 2B). High-throughput
sequencing of ribo-depleted RNA from knockdown samples
confirmed increased read density downstream of the mature 30
end of hTR, as well as an increase in hTR PROMPT reads, in
particular for the RRP40 depletion (Figure 2C). This accumulation
of 30 extended forms of hTR in exosome-depleted cells supports
the notion that the exosome either processes 30 extended forms
into mature hTR or is responsible for their degradation.
To assess whether longer forms are preferentially degraded or
processed, we cloned the hTRH/ACA box (nucleotides 206–451)
and placed this 246-nt double-hairpin (DH) structure either 50 or
250 nt downstream of position 451 (Figure S3, shown in red). If 30
extended forms of 750 nt or more normally give rise to the
mature form via exonucleolytic trimming, processing will now
be attenuated at the second H/ACA box placed downstream
and a longer product will be formed at the expense of the
451-nt RNA. If, however, longer transcripts are normally
degraded, then the same amount of 451-nt RNA will be pro-
duced in the presence and absence of the downstream H/ACA
box. The longer forms, which are normally degraded, may give
rise to an additional stable product visible in the form of a slower
migrating band only if transcription extends beyond the 30 end of
the newly introduced H/ACA box. Expression of the double
H/ACA box constructs and wild-type hTR control in VA13 cells
revealed similar amounts of 451-nt RNA (Figure 2D). Each of
the double H/ACA box constructs produced an additional
band of the expected size with substantially more product
observed when the second H/ACA box was placed closer to
position 451. These results indicate that long transcripts are pre-
dominantly degraded and that most transcripts are shorter than
1,000 nt.orts 13, 2232–2243, December 15, 2015 ª2015 The Authors 2233
Figure 1. Isoginkgetin Mimics the Effects of
Inhibiting the RNA Exosome
(A) HeLa S3 cells were treated with 35 mM iso-
ginkgetin or DMSO for 12 hr. Total RNA was pre-
pared and subjected to qRT-PCR for hTR,GAPDH,
ATP5b, and HPRT. Positions of primers used
to detect the mature and 30-extended forms of
hTR are indicated with arrows in the schematic.
Bar graph of mean fold change for hTR relative
to DMSO-treated samples and normalized to
GAPDH, ATP5b, and HPRT. Mean values were
calculated from triplicate qRT-PCR experiments
of three biological replicates, with bars represent-
ing SE.
(B) Splicing defect in HeLa S3 cells treated
with 35 mM isoginkgetin, DMSO, 200 nM
spliceostatin A, or methanol for 12 hr. RNA-
sequencing (RNA-seq) reads from ribo-depleted
RNA were mapped using TopHat. Box plots were
generated from the aggregate of 83,846 iso-
ginkgetin and 85,427 (spliceostatin A) splicing
units by calculating percent spliced out (PSO)
values based on reads spanning the exon-exon
junction relative to the sum of exon-intron, exon-
exon, and intronic reads.
(C) Bar graphs showing quantification of RNA-seq
reads mapping to genomic regions upstream
(730 to270), within (+1 to +451), or downstream
(+452 to +1,451) of hTR locus. The region of
PROMPT, mature hTR, and 30-extended hTR are
indicated in the top schematic. All reads were
normalized to library size. Mean values were
calculated from three replicates, with bars repre-
senting SE.Implication of NEXT and CBCA in the Turnover of 30
Extended Forms
The exosome is directed to its diverse RNA substrates and regu-
lated in its activity by different adaptor and activator complexes
(Mitchell, 2014). Two such complexes are prominent in the nu-
cleus: the human homolog of the yeast Trf4/Air2/Mtr4 polyade-
nylation (TRAMP) complex and the nuclear exosome targeting
(NEXT) complex. Human TRAMP is comprised of the Air2 homo-
log ZCCHC7, the non-canonical poly(A) polymerase TRF4-2/
PAPD5 (Trf4 in yeast) and the MTR4 subunit, which is shared
with NEXT. NEXT is composed of MTR4, ZCCHC8, and RBM7
(Lubas et al., 2011; Schilders et al., 2007). NEXT has been found
to participate in the processing and elimination of a variety of
RNAs, including PROMPTs, 30-extended forms of snRNAs, and
replication-dependent histone (RDH) transcripts (Andersen
et al., 2013; Lubas et al., 2011), the same classes of RNAs we
had seen increased upon isoginkgetin treatment.
Supporting a role for the NEXT complex in the turnover of
hTR 30 extended forms, knockdown of ZCCHC8 and RBM7 (Fig-
ure 3A) increased the steady-state level of 30-extended hTR (Fig-
ure 3B). In contrast, knockdown of the TRAMP-specific factor2234 Cell Reports 13, 2232–2243, December 15, 2015 ª2015 The AuthorsZCCHC7 had no effect, and TRF4-2 small
interfering RNA (siRNA) treatment re-
sulted in a small increase discussed
further below.Most strikingly, knockdown
of the shared component MTR4 caused amore than 12-fold increase in hTR 30 extended forms (Figure 3B).
This may be explained by differences in knockdown efficiency,
co-depletion of ZCCHC8 in the MTR4 knockdown (Figure 3A,
left panel, lane 2), or cumulative effects of NEXT-dependent
and -independent roles of MTR4 in hTR processing.
The cap binding complex A (CBCA) is composed of the cap-
binding proteins 20 (CBP20) and 80 (CBP80) and arsenic-resis-
tance protein 2 (ARS2). It binds the 7-methyl guanosine cap on
nascent RNA pol II transcripts and, upon recruitment of
ZC3H18 and NEXT, forms CBCA-NEXT, also known as CBCN
(Andersen et al., 2013; Lubas et al., 2015). CBCN thereby links
50 capping to transcription termination and exosome-mediated
30 end processing or degradation (Figure 3C). Depletion of
CBCN components causes increases in a subset of exosome
substrates including PROMPTs and 30 extended forms of U1
and U2 snRNAs (Andersen et al., 2013). We found that depletion
of CBP80 (Figure 3D) resulted in a close to 3-fold increase in the
30 extended forms of hTR, whereas siRNAs against ARS2 and
ZC3H18 only caused small increases (Figure 3E). A more pro-
nounced effect of CBP80 over ARS2 knockdown has also
been observed in the context of pre-U2 accumulation (Andersen
Figure 2. Longer Forms of hTR Are Prefer-
entially Degraded
(A) Western blotting analysis of cell extracts pre-
pared from HeLa cells treated with siRNAs tar-
geting RRP40 (lane 2), RRP6 and DIS3 (lane 4),
RRP6 (lane 6), and DIS3 (lane 8), respectively. Non-
targeting siGENOME pool was used as control
(lanes 1, 3, 5, and 7). Endogenous TUBULIN served
as a loading control.
(B) Total RNA prepared from HeLa cells treated
with the indicated siRNAs was subjected to qRT-
PCR for 30-extended hTR, GAPDH, ATP5b,
and HPRT. Bar graph of mean fold change for
30-extended hTR relative to control siRNA-treated
samples and normalized to GAPDH, ATP5b, and
HPRT. Mean values were calculated from triplicate
qRT-PCR experiments of three biological repli-
cates, with bars representing SE.
(C) Total RNA prepared from HeLa cells treated
with 35 mM isoginkgetin or the indicated siRNAs
was subjected to RNA-seq. RNA-seq reads map-
ping to genomic regions upstream (730 to270),
within (+1 to +451), or downstream (+452
to +1,451) of hTR locus were normalized to library
size. Y-axis represents the fold change in the
indicated siRNA-treated samples relative to con-
trol siRNA or isoginkgetin-treated samples relative
to DMSO control. Bars represent SE.
(D) pCR-XL-TOPO cloning vectors containing
wild-type hTR or hTR harboring an additional
double-hairpin structure of box H/ACA (fragments
correspond to nucleotides 206–451 of hTR) in-
serted 50 nt (double hairpin 50 nt downstream of
hTR [DH-50], products corresponding to 750 nt
in length) or 250 nt (double hairpin 250 nt down-
stream of hTR [DH250], products corresponding to
1,000 nt in length) downstream of the mature 30
end (position 451) were transfected into the telo-
merase-negative VA13 cells. Total RNA was pre-
pared and subjected to northern blots. A probe
against neomycin served as control for trans-
fection efficiency and loading. An asterisk repre-
sents background resulted from pCR-XL-TOPO
cloning vectors.et al., 2013) and may reflect redundancy in factors connecting
CBP20/80 with NEXT or a CBCA-independent role of CBC.
Our results argue that the processing of 30-extended hTR is
mediated by CBC and NEXT and results primarily in degradation
by the exosome. However, a fraction of transcripts must be pro-
cessed into the mature form.
The Exosome, TRAMP, and CBC Function in hTR
Processing
When hTR is examined by northern blotting, the dominant form
appears as a distinct band. This form is generally referred to as
the mature form, but the resolution afforded by 4% polyacryl-
amide gels does not permit distinction between the 451-nt
mature RNA and slightly longer or shorter forms. Depletion of
exosome components RRP40, RRP6, or RRP6/DIS3 caused
an increase in this band (Figures 4A and S4). The effects were
modest but highly reproducible over biological triplicates.
Consistent with RRP6 being primarily responsible for the turn-
over of hTR, the 451-nt RNA was increased by 1.4-fold uponCell RepRRP6 knockdown but did not change upon DIS3 knockdown
(Figure 4A).
Next, we examined the effects of TRAMP, NEXT, and CBCA
knockdowns on hTR levels on northern blots. 2- to 3-fold in-
creases were observed upon knockdown of MTR4 and CBP80,
with smaller effects supporting roles for TRAMP and CBC in
hTR turnover (Figure 4B). Knockdown of NEXT components
ZCCHC8 and RBM7 had no effect. In aggregate, these data sug-
gest that CBC, TRAMP, and the exosome are involved in the
degradation of hTR forms that are 451 nt in length, whereas
NEXT plays a role in the degradation of longer transcripts.
To gain further insights into how the 451-nt mature form is pro-
duced, we performed RLM-RACE (RNA ligase-mediated rapid
amplification of cDNA ends) coupled with high-throughput
sequencing. In samples treated with control siRNA, 75%–
79% of hTR molecules matched the hTR sequence to position
451, 4%–6% were truncated by up to 4 nt, and 14%–18%
extended beyond position 451 (Figure 4C). Consistent with an
earlier report that examined hTR 30 ends (Goldfarb and Cech,orts 13, 2232–2243, December 15, 2015 ª2015 The Authors 2235
Figure 3. Implication of NEXT and CBCA in
30-Extended hTR Turnover
(A) Western blotting analysis of cell lysates from
HeLa cells treated with siRNAs against NEXT or
TRAMP subunits. TUBULIN served as a loading
control.
(B) Total RNA prepared from HeLa cells treated
with the indicated siRNAs was subjected to qRT-
PCR for 30-extended hTR, GAPDH, ATP5b, and
HPRT. Mean fold change for 30-extended hTR
relative to control siRNA and normalized to multi-
ple reference genes. Mean values were calcu-
lated from triplicate qRT-PCR experiments for
each of two or three biological replicates. Bars
represent SE.
(C) A schematic of exosome recruitment by CBCA
and the NEXT complex.
(D) Western blot of cell lysates from HeLa cells
treated with siRNAs against CBCA components.
TUBULIN served as a loading control.
(E) qRT-PCR for 30 extended forms of hTR was
performed as described in (B). Mean values were
calculated from triplicate qRT-PCR experiments
for each of two or three biological replicates, with
bars representing SE.2013), a fraction of molecules terminated in non-templated
adenosines (Figure S5A). As the genome encodes for an adeno-
sine at position 452, we cannot distinguish between mono-ad-
enylated mature hTR and precursor terminating at position
452, but 2% of hTR fell into this category (Figure S5A, shown
in medium green). Knockdown of TRF4-2 reduced the oligo-ad-
enylated fraction by 10-fold (Figure S5A,middle panel). A smaller
decrease was observed following depletion of the TRAMP sub-
unit ZCCHC7. This was not the case for the MTR4 knockdown,
where oligo-adenylated forms increased, supporting the notion
that TRF4-2 is responsible for oligo-adenylation of hTR with
MTR4 playing a role downstream of oligo-adenylation in the
degradation of hTR (Figure S5A).
Surprisingly, we found that knockdown of the exosome,
CBCA, and ZC3H18 caused decreases in the fraction of2236 Cell Reports 13, 2232–2243, December 15, 2015 ª2015 The Authorsoligo-adenylated hTR (Figure S5A). Exo-
some depletion reduced oligo-adeny-
lated hTR by 2- to 3-fold (Figure S5A,
left). More dramatic effects were
observed upon CBCA knockdown.
Knockdown of CBP80 and ARS2
reduced the oligo-adenylated fraction
by 5.8-fold and 10-fold, respectively
and, like si-TRF4-2, increased the frac-
tion of mature hTR (Figure S5A, right).
A decrease in oligo-adenylated hTR
caused by TRAMP and CBC knock-
downs was further confirmed by oligo
d(T)-primed qRT-PCR (Figure S5B).
Consistent with observations of 30
sequencing analyses, oligo-adenylated
hTR was decreased by 90% and 70%
upon TRF4-2 and CBP80 knockdown,respectively. In addition to a reduction in oligo-adenylation,
we also found that knockdown of the exosome, TRAMP, and
CBCA reduced the fraction of hTR that is slightly longer than
451 nt, resulting in further increases in the mature form of
hTR (Figure 4C, shown in light blue). Compared to the control
(14%–18%), the slightly longer form of hTR was reduced by
knocking down the TRAMP components ZCCHC7 (5%) and
TRF4-2 (3%) as well as the CBCA components CBP80 (2%),
ARS2 (2%), and ZC3H18 (6%). Taken together, our data
show that longer and oligo-adenylated forms of hTR are the
precursor of the 451-nt mature RNA. Surprisingly, processing
is attenuated in the presence of CBCA, TRAMP, and the exo-
some. This is inconsistent with a model in which the hTR pre-
cursor is processed by the CBCA/TRAMP/exosome complex.
Instead, hTR maturation must be mediated by other nucleases
Figure 4. The Exosome, TRAMP, and CBC
Function in hTR Processing
(A and B) Total RNA prepared from HeLa cells
treated with the indicated siRNAs. Bar graph of
mean fold change for hTR levels relative to control
siRNA-treated samples and normalized to GAPDH
RNA for the exosome (A), TRAMP and NEXT
knockdown (B), and to 7SL RNA for CBCA
knockdown (B). Mean values were calculated from
northern blot experiments of three biological rep-
licates. Bars represent SE.
(C) Pie chart illustrating distribution of the 30 end
position. 30-truncated (%450), mature (451), and
longer (R453) forms of hTR are shown in light or-
ange, green, and blue, respectively. Position 452 is
shown in medium green. 30 ends were determined
by RNA ligase-mediated 30 RACE approach.
Number of reads analyzed: si-Ctrl (RRP40),
1412759; si-RRP40, 1412507; si-Ctrl (RRP6/DIS3),
1447919; si-RRP6/DIS3, 1485973; si-Ctrl
(TRAMP), 1220990; si-MTR4, 1459392; si-
ZCCHC7, 1333722; si-TRF4-2, 1281656; si-Ctrl
(CBCA), 1072013; si-CBP80, 1346541; si-ARS2,
1501889; si-ZC3H18, 1353612.that are in competition with degradation of the RNA by CBC,
TRAMP, and the exosome (Figure S5C).
PARN Processes the 30 End of hTR
Our results suggest an unanticipated role for CBCA in inhibiting
processing of hTR precursors by an activity that is in competition
with the TRAMP/exosome complex (Figure 4). Three recent
studies have implicated the poly(A)-specific ribonuclease
PARN in telomere biology through the identification of mutations
in patients with severe dyskeratosis congenita (Dhanraj et al.,
2015; Stuart et al., 2015; Tummala et al., 2015). Although the
reported reduction in hTR levels in patient samples could be
an indirect consequence of reduced levels of dyskerin and other
proteins involved in telomere biology (Tummala et al., 2015), an
earlier report had implicated PARN in the processing of intron-
encodedH/ACA box snoRNAs (Berndt et al., 2012). Interestingly,
CBC has been shown to act as a negative regulator of PARN-
mediated processing and CBP80 alone inhibits PARN activity
in an m7G cap-independent manner (Balatsos et al., 2006). We
therefore wondered whether PARN affected hTR biogenesis by
processing the oligo-adenylated precursor of hTR. To examine
the effect of PARN depletion on the extent of oligo-adenylation
and steady-state level of precursor, we depleted PARN from
HeLa cells (Figure 5A). PARN knockdown did not substantiallyCell Reports 13, 2232–2243, Dereduce the box H/ACA components at
the protein level, although a shift of
DKC1 to a faster-migrating form was
observed (Figure 5A, lane 2). Oligo-ad-
enylated hTR was increased by 5-fold
upon PARN knockdown, as measured
byoligod(T)-primedqRT-PCR (Figure5B).
Sequencing of hTR 30 ends after RLM-
RACE revealed that precursor was
increased by 2-fold at the expense ofthe 451-nt form (Figure 5C). These data support that PARN
depletion results in deficiencies in the 30 end processing of hTR.
To further confirm the role of PARN in hTR 30 end processing,
we overexpressed PARN in HeLa cells (Figure 5D). This did not
significantly affect the steady-state level of hTR based on north-
ern blots (Figure S6) but reduced oligo-adenylated hTR by over
30%, as measured by oligo d(T)-primed qRT-PCR (Figure 5E).
30 end sequence analysis revealed that the hTR precursor is
reduced by 38% (Figure 5F), suggesting that PARN is involved
in the deadenylation/30 end trimming of hTR.
Processing by PARN Is in Competition with Degradation
Knockdown of CBP80 and ARS2 greatly reduced the fractions of
both precursor and oligo-adenylated forms of hTR (Figures 4 and
S5), indicating that 30 end processing is more efficient in the
absence of CBCA. If PARN is the enzyme that trims the 30 end
of hTR precursor in the absence of CBCA, the hTR precursor
should be stabilized in the absence of PARN and CBP80. We
simultaneously knocked down PARN and CBP80 in HeLa cells
(Figure 6A). Cells depleted of PARN and CBP80 indeed accumu-
lated oligo-adenylated hTR (Figure 6B), supporting that CBP80
negatively regulates PARN activity.
Knockdown of CBC, TRAMP, and the exosome not only stabi-
lized hTR levels but also facilitated the 30 end processing of hTRcember 15, 2015 ª2015 The Authors 2237
Figure 5. PARN Processes the 30 End of hTR
(A) Western blotting analysis of cell lysates from
HeLa cells treated with siRNAs against PARN.
Antibodies against PARN, dyskerin, NAF1, NHP2,
and NOP10 were used. TUBULIN served as a
loading control.
(B) Bar graph shows the mean fold change for
oligo-adenylated hTR fraction relative to control
siRNA and normalized to multiple reference genes.
Oligo-adenylated hTR was measured by qRT-PCR
using oligo dT primer for reverse transcription and
cDNA amplification was done using hTR-specific
primers. Mean fold changes were calculated from
triplicate qRT-PCR experiments for each of three
biological replicates, with bars representing SE.
(C) Pie chart illustrating distribution of the 30 end
position. 30-truncated (%450), mature (451), and
longer (R453) forms of hTR are shown in light or-
ange, green, and blue, respectively. Position 452 is
shown in medium green. 30 ends were determined
using an RNA ligase-mediated 30 RACE approach.
Number of reads analyzed: si-Ctrl, 1761073; si-
PARN, 1310308.
(D) Western blotting analysis of cell lysates from
HeLa cells transfected with pCMV6-XL-PARN
plasmid. Antibodies against PARN, dyskerin,
NAF1, NHP2, and NOP10 were used. TUBULIN
served as a loading control.
(E) Bar graph shows the mean fold change for
oligo-adenylated hTR fraction relative to vector
and normalized to multiple reference genes. Oligo-
adenylated hTR was measured as described in (B). Mean fold changes were calculated from triplicate qRT-PCR experiments for each of three biological rep-
licates, with bars representing SE.
(F) Pie charts illustrating distribution of 30 end position as described in (C). Number of reads analyzed: vector, 1,223,760; PARN overexpression, 1,351,439.precursors (Figure 4), indicating that degradation by CBC/
TRAMP/exosome is in competition with PARN-mediated pro-
cessing. We therefore wondered whether PARN deficiency
affected the steady-state level of hTR. Knockdown of PARN in
HeLa cells resulted in a 30% decrease in hTR by northern blots
(Figure 6C, lane 2). Although we cannot rule out the possibility
that reduced stability of hTR is an indirect effect, the observation
that PARN knockdown caused a reduction in hTR fits the
model that PARN functions in the precise trimming of hTR, a pro-
cess that is in competition with degradation of these forms by the
exosome aided by CBC and TRAMP. Consistent with this notion,
simultaneous knockdown of PARN and any of several factors
involved in the degradation of hTR rescued the mature form to
wild-type levels (Figures 6C and 6D).
In aggregate, our data support amodel in which long hTR tran-
scripts are predominantly degraded by a pathway involving
CBC, NEXT, and the exosome (Figure 7). A fraction of transcripts
(hTR precursor) are oligo-adenylated, at least in part, by TRF4-2
and either degraded by the exosome or processed into mature
form by PARN.
DISCUSSION
The exosome plays a central and evolutionarily conserved role in
the processing, quality control, and degradation of many classes
of RNAs (Houseley et al., 2006; Lykke-Andersen et al., 2009;
Schneider and Tollervey, 2013). Here, we have shown that inhi-2238 Cell Reports 13, 2232–2243, December 15, 2015 ª2015 The Aubition of exosome activity by isoginkgetin or knockdown results
in accumulation of long hTR transcripts that are normally
degraded by the exosome in conjunction with CBCA and
NEXT. Shorter precursors of hTR are oligo-adenylated in a pro-
cess that depends on CBCA and TRAMP and are converted
into mature hTR in a PARN-dependent manner. Maturation is
therefore in competition with degradation by the exosome
(Figure 7).
Diversity and Conservation in Telomerase RNA
Processing
Substantial differences in TER biogenesis had been anticipated
due to the fact that yeast telomerase RNAs share properties
with snRNAs (Leonardi et al., 2008; Seto et al., 1999; Webb
and Zakian, 2008), whereas mammalian telomerase RNA sub-
units resemble H/ACA box snoRNAs (Chen et al., 2000; Mitchell
et al., 1999a). Even among yeasts, mechanisms for 30 end
processing differ substantially. Whereas diverse yeasts and fila-
mentous fungi rely on spliceosomal cleavage for 30 end pro-
cessing of TER, S. cerevisiae TLC1 lacks an intron downstream
of its mature 30 end, and transcriptional termination and pro-
cessing involves the Nrd1-Nab3-Sen1 (NNS) pathway (Jamon-
nak et al., 2011; Noe¨l et al., 2012). Although human cells
contain a homolog of Sen1, senataxin (Moreira et al., 2004),
no homologs of Nrd1 or Nab3 have been identified, and there
is presently no evidence supporting a role for senataxin in
hTR biogenesis.thors
Figure 6. Processing by PARN Is in Compe-
tition with Degradation
(A) Western blotting analysis of cell lysates from
HeLa cells treated with siRNAs against PARN and/
or CBP80. TUBULIN served as a loading control.
(B) Bar graph shows the mean fold change for
oligo-adenylated hTR fraction relative to control
siRNA and normalized to multiple reference genes.
Oligo-adenylated hTRwasmeasured as described
in Figure 5B. Mean fold changes were calcu-
lated from triplicate qRT-PCR experiments for
each of three biological replicates, with bars rep-
resenting SE.
(C) Northern blotting analysis of hTR from HeLa
cells treated with siRNA against PARN alone or in
combination with other factors as indicated.
A probe against 7SL RNA served as a loading
control.
(D) Bar graph shows the ratios of knockdown over
control were normalized to 7SL RNA. Mean values
were calculated from northern blot experiments of
three biological replicates. Bars represent SE.
Significance of change in hTR level between
samples was calculated with a Student’s t test;
*p < 0.05, **p < 0.01, ***p < 0.005.Accumulation of 30 extended forms of hTR upon knockdown of
exosome, CBCA, or NEXT components supports a model in
which CBC and the NEXT complex associate with hTR co-tran-
scriptionally and recruit the exosome for 30 end processing and/
or degradation. A similar connection was observed between the
CBCandNNScomplexes inS. cerevisiae (Vasiljeva andBuratow-
ski, 2006), indicating that functional similarities may exist even
though NNS and NEXT components are not related in sequence.
The association of the core exosome with two nucleases and
cofactorswithdiscretepropertiesandofdistinct subcellular distri-
bution are key features that provide specificity in the processing
and degradation of different target RNAs. In human cells, spatial
compartmentalization of different targeting complexes may
further increase specificity of processing and degradation (Lubas
etal., 2011).ZCCHC7 is stronglyenriched in thenucleolus (Fasken
et al., 2011; Lubas et al., 2011), suggesting that the TRAMP com-
plex predominantly functions in this compartment. In contrast,
RBM7 and ZCCHC8 are nucleoplasmic, consistent with a role
for NEXT in recruiting the exosome to nascent transcripts (Lubas
et al., 2011). While initial processing of 30-extended hTR occurs
co-transcriptionally in the nucleoplasm and is a prerequisite for
translocation into the Cajal body (Theimer et al., 2007), degrada-
tion of mature hTRmay occur in the nucleolus based on ZCCHC7
localization. The nucleolar exosome lacks DIS3 (Lubas et al.,
2011), which could in part explain why depletion of DIS3, unlike
RRP6, had no effect on mature hTR levels. However, current
data do not exclude the possibility that a fraction of the longer
forms escapes degradation and is processed into mature form.Cell Reports 13, 2232–2243, DeKinetic Competition between
Processing and Degradation
Haploinsufficiency for telomerase RNA
has been demonstrated in budding yeast
(Mozdy and Cech, 2006), mice (Hathcocket al., 2002), and humans (Marrone et al., 2004). In each system,
reductions in the levels of telomerase RNA of as little as 30% to
50% result in telomere shortening. The effects of manipulating
the activities of RNA processing factors reported here are there-
fore expected to have physiological consequences. Based on
our data, the amount of mature hTR is determined in a kinetic
competition between processing and degradation (Figure 7).
The increase in all forms of hTR observed following MTR4,
RRP40, or RRP6 knockdown indicates that a substantial fraction
of hTR transcripts are normally degraded. The notion that pre-
cursor degradation limits hTR accumulation is also supported
by the observation that insertion of a self-cleaving ribozyme
immediately downstream of the mature 30 end resulted in
increased accumulation of mature form (Egan and Collins,
2012b).
The broad association of human CBC with the 50 ends of pol II
transcripts and the promiscuous binding of RBM7 to U-rich se-
quences on nascent RNA creates a surveillance mechanism to
target the exosome to unprotected 30 ends (Andersen et al.,
2013; Lubas et al., 2015). PROMPTs and extended transcripts
of replication-dependent histones and snRNAs are transcription-
ally terminated and subsequently degraded in this manner. The
accumulation of 30 extended forms of hTR upon knockdown of
CBC or NEXT components indicates that hTR transcripts enter
the same pathway. What is less clear is whether CBCN-medi-
ated termination necessarily leads to degradation of 30 extended
hTR or whether degradation turns into processing for a fraction
of transcripts. This decision is likely affected by how rapidlycember 15, 2015 ª2015 The Authors 2239
Figure 7. Schematic Illustrating the
Different Functions for PARN and the Exo-
some and Associated Factors in Telome-
rase RNA Biogenesis and Turnover in
Human Cellsthe RNA folds and is bound by the dyskerin complex that can
protect it. Formation of the H/ACA RNP may attenuate degrada-
tion by the exosome and provide an opportunity for a switch to
processing. Indeed, efficient co-transcriptional assembly of the2240 Cell Reports 13, 2232–2243, December 15, 2015 ª2015 The Authorsdyskerin-NOP10-NHP2-NAF1 complex
on the H/ACA domain is critical for the
accumulation of the mature form of hTR,
and depletion of any of a number of chap-
erones that promote this process reduces
the steady-state level of mature hTR
(Boulon et al., 2008; Fu and Collins,
2007; Grozdanov et al., 2009; Hoareau-
Aveilla et al., 2006; Venteicher et al.,
2008). It therefore appears likely that as-
sembly of an intact dyskerin complex is
the key determinant that attenuates 30 to
50 degradation near the mature 30 end;
otherwise, the RNA is degraded in its en-
tirety (Figure 7). Coupling successful RNP
assembly to processing instead of degra-
dation creates an effective quality control
pathway for hTR biogenesis akin to what
has previously been reported for snRNAs
(Shukla and Parker, 2014).
Processing intermediates are oligo-ad-
enylated by TRF4-2 and then have one of
multiple fates. First, they may be directly
processed intomature hTRbyPARN. Pro-
cessing by PARN will be favored if the 50
end is mono-methyl guanosine (MMG)
capped and available for binding by
PARN (Balatsos et al., 2006). CBC acts
as a negative regulator of PARN-mediated
processing at this stage by competing
with PARN for cap binding. An additional
layer of regulation may come from the
hypermethylation of the MMG cap by the
trimethyl guanosine synthase TGS1
(PIMT; Zhu et al., 2001) once hTR has
translocated to a Cajal body. Second,
short oligo(A) tails synthesized by
TRF4-2 may be extended by canonical
poly(A) polymerases and boundby the nu-
clear poly(A)-binding protein (PABPN1).
PABPN1 has been found to interact with
PARN, and PABPN1 depletion reduces
mature hTR levels and causes telomere
shortening (Nguyen et al., 2015, this issue
of Cell Reports). It thus appears that
PABPN1 is another important player ingenerating mature form of hTR, presumably by transiently stabi-
lizing adenylated intermediates and recruiting PARN or RRP6.
Finally, oligo-adenylated processing intermediates could also
become substrates of MTR4, resulting in their processive
degradation by the exosome. The balance between those fates
determines the amount of mature hTR that is produced.
In summary, these results show that processing and degrada-
tion of hTR precursors are in kinetic competition and favoring
one process over another shifts the balance to generate more
or less mature form. This establishes a framework for how
mature hTR is generated from longer transcripts and how subtle
shifts in the balance between competing pathways affects the
amount of functional telomerase RNA that is ultimately pro-
duced. A clear understanding of the mechanisms involved in
hTRmaturation and turnover holds promise for medical interven-
tion in cases where a mutation in a processing factor shifts the
balance toward degradation, resulting in a lower steady-state
level of hTR, insufficient telomerase activity, and premature telo-
mere shortening. The finding that most of the hTR transcripts are
normally degraded is encouraging in that attenuation of degra-
dation may be used to boost the level of functional telomerase
RNA in patients with telomerase insufficiency syndromes caused
by low levels of hTR.
EXPERIMENTAL PROCEDURES
Cell Culture and RNAi Analysis
HeLa cells were cultured in DMEM (Life Technologies, 11995-065) containing
10% fetal bovine serum (Sigma-Aldrich) at 37C, 5% CO2. VA13 cells (WI38
VA13 subline 2RA purchased from American Type Culture Collection
[ATCC]) were cultured in ATCC formulated Eagle’s minimum essential medium
(ATCC 30-2003) with 10% fetal bovine serum (Sigma) at 37C, 5% CO2. Se-
quences of siRNAs are listed in Table S1. For isoginkgetin and spliceostatin
A treatment, isoginkgetin was purchased from EMD Millipore Chemicals
(vendor part #CAS548-19-6). Spliceostatin A was a gift from Dr. Minoru Yosh-
ida. HeLa S3 cells were treated with 35 mM isoginkgetin and 200 nM spliceos-
tatin A, respectively, for 12 hr. Control cells were treated with DMSO (0.1% v/v)
for isoginkgetin and methanol (0.1% v/v) for spliceostatin A. For siRNA knock-
down, cells were treated twice (2- or 3-day interval) with 20 nM or 40 nM siRNA
using Dharmafect I (Dharmacon). For PARN overexpression, PARN-pCMV6-
XL (Origene, SC325208) was transfected into HeLa cells using Fugene HD
(Promega) for 72 hr. For western blotting analysis, cells were lysed in a solution
containing 23 LDS sampling buffer (Life Technologies), 0.78% b-mercaptoe-
thanol (v/v) (J.T. Baker), and 4% SDS. Antibodies used for western blotting are
listed in Table S2.
qRT-PCR
Cells were washed once with Dulbecco’s PBS and collected in Trizol reagent
(Ambion, Life Technologies) according to the manufacturer’s instructions, fol-
lowed by treatment with DNase I (New England Biolabs) at 37C for 30 min.
RNA was extracted with phenol/chloroform equilibrated with 50 mM NaOAc
(pH 5.0) and ethanol precipitated. RNA was used for qRT-PCR and northern
blotting analyses. Reverse-transcription reactions (20 ml) containing 2 mg
RNA, 13 Vilo reaction mix (Life Technologies, 11754-250), and 13 Superscript
III enzyme blend (Life Technologies, 11754-250) were incubated at 25C for
10 min, 42C for 1 hr, and 85C for 5 min in a PCR machine. Reactions were
then diluted 25-fold with water. Forward and reverse primers used for qPCR
are listed in Table S3. The diluted cDNA and pre-mix components (13 Perfecta
SYBR green fastmix ROX, 625 nM forward and reverse primers) were mixed in
a 384-well microplate by a CAS4200 robot, and qPCR reactions were
performed in triplicates in a 7900 HT Fast Real-Time PCR system. All data
were normalized to multiple reference genes (GAPDH, ATP5b, and HPRT) by
Biogazelle’s qbase+ software.
Northern Blot
For northern analysis of hTR, 10 mg total RNA was used. RNA was separated
on a 4% polyacrylamide (29:1) gel containing 8 M urea and transferred toCell RepHybond-N1 nylon membrane (GE Healthcare) at 400 mA for 1 hr in 0.53
TBE buffer. RNA was cross-linked to the membrane in a Stratalinker (Stra-
tagene; 254 nm, 120 mJ). Hybridizations with radiolabeled probes were per-
formed in Church-Gilbert buffer at 65C (hTR, and GAPDH probes generated
by nick-translation of a PCR fragment in the presence of 32P-a-dCTP) or
42C for the oligonucleotide probe against 7SL (BLoli5349) and neomycin
(BLoli2948). Oligonucleotides used for preparation of probes are listed in
Table S4 and were labeled with T4 polynucleotide kinase in the presence
of 32P-g-ATP.
RNA-Ligase-Mediated 30 RACE with Deep Sequencing
Library preparation was based on a published protocol (Goldfarb and Cech,
2013). Oligonucleotides used for library preparation are listed in Table S5.
Ligation reactions contained 1.5 mg DNase I-treated total RNA, 3.7%
PEG8000, 7.4% DMSO, 13 T4 RNA ligase buffer, 10 U T4 RNA ligase I,
0.7 mM ATP, and 3.7 mM 30 linker (BLoli5511, IDT miRNA linker 3). The liga-
tion reaction was incubated at 16C for 18 hr and inactivated at 65C for
15 min. RNA ligation reactions were annealed with 1.6 mM RT primer
(BLoli5575) and 0.5 mM dNTPs at 65C for 5 min, cooled down to room tem-
perature for 10 min, and transferred to 55C for reverse transcription in 30 ml
volumes containing 13 First Strand buffer, 5 mM DTT, 40 U RNasin plus
RNase inhibitor (Promega), and 300 U Superscript III (Invitrogen) for
60 min. 10 U RNase H was added into the reverse transcription reaction, fol-
lowed by incubation at 37C for 20 min and heat-inactivation at 70C for
15 min. The first round PCR was performed with 0.5 mM BLoli5575 and
BLoli5574 in 50 ml volumes containing 13 Phusion HF buffer, 0.2 mM dNTPs,
1 U Phusion Hot Start II polymerase (Thermo Scientific) using the following
program: 98C for 30 s, 15 cycles of 98C for 30 s, 57C for 30 s, 72C
for 30 s, and final extension at 72C for 10 min. First-round PCR products
were purified by PCR purification kit (QIAGEN). Then, 5 ml of 103-diluted
first-round PCR product was used as template for the second round PCR re-
actions containing 0.5 mM BLoli4666 and respective indexed primers as indi-
cated in Table S5, 13 Phusion HF buffer, 0.2 mM dNTPs, and 1 U Phusion
Hot Start II polymerase with the following program: 98C for 30 s, 15 cycles
of 98C for 30 s, 57C for 30 s, 72C for 30 s, and final extension at 72C for
10 min. Amplicons were purified by PCR purification kit (QIAGEN) and the
primer dimers were removed using the Pippin Prep System (Sage Science),
then quantified by Qubit and Bioanalyzer. The samples were sequenced on
the Illumina HiSeq using RapidSeq 100-bp single-end reads. The samples
were multiplexed and split between two lanes. There are 2.1 to 13.6 million
reads per sample after filtering for quality. Reads were binned into the
various forms of hTR using custom python scripts, and the number of reads
in each bin was normalized to library size.ACCESSION NUMBERS
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